CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce that NOTOCORD®, now part of the Instem Group, has released the latest version of its world-leading NOTOCORD-hem™ software solution.
NOTOCORD-hem is an advanced software platform for the acquisition, display and analysis of physiological signals, with a focus on the areas of Cardiovascular, Respiratory and Nervous System research. This latest release, version 188.8.131.52, offers users further improved GLP compliance and is compatible with DSI Hardware Configuration 1.8 and Stellar Telemetry implantable devices.
“This is an excellent achievement and an important release for NOTOCORD-hem customers,” comments Gregor Grant, Executive Vice President at Instem. “This is an important step in the road to a more Open Strategy, facilitating greater choice and driven by the needs of our customers. We look forward to connecting NOTOCORD-hem to more and more 3rd party signal acquisition, hardware and telemetry devices. We believe there is a strong call for more data collaboration and access which ultimately aids data-driven decision making; improving the science and leading to safer, more effective products.”
NOTOCORD-hem is an advanced software platform designed to acquire, display and analyze physiological signals. Covering Cardiovascular, Respiratory and Nervous system research areas, NOTOCORD-hem offers:
- Over 160 modules for a customized analysis
- In vivo, In vitro and Ex vivo
- Large range of hardware compatibility from analogue to implantable devices
- Simultaneous acquisition from different sources and systems
- Flexible user interfaces offering easy configuration and displays
- Ultra-fast access to data regardless of experiment file size
- Unique Microsoft Excel® Add-in for individualized reporting
- Compliance with GLP & 21 CFR Part 11
Instem is a leading supplier of IT applications and services to the early development healthcare market delivering compelling solutions for data collection, analysis and regulatory submissions management. Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions and consulting services increases client productivity by enhancing product development processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.